The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders
Abstract
Summary: Background: Peppermint oil has been used for centuries as a treatment for gastrointestinal ailments. It has been shown to have several effects on gastrointestinal physiology relevant to clinical care and management. Aim: To review the literature on peppermint oil regarding its metabolism, effects on gastrointestinal physiology, clinical use and efficacy, and safety. Methods: We performed a PubMed literature search using the following terms individually or in combination: peppermint, peppermint oil, pharmacokinetics, menthol, oesophagus, stomach, small intestine, gallbladder, colon, transit, dyspepsia, nausea, abdominal pain, and irritable bowel syndrome. Full manuscripts evaluating peppermint oil that were published through 15 July 2017 were reviewed. When evaluating therapeutic indications, only randomised clinical trials were included. References from selected manuscripts were used if relevant. Results: It appears that peppermint oil may have several mechanisms of action including: smooth muscle relaxation (via calcium channel blockade or direct enteric nervous system effects); visceral sensitivity modulation (via transient receptor potential cation channels); anti‐microbial effects; anti‐inflammatory activity; modulation of psychosocial distress. Peppermint oil has been found to affect oesophageal, gastric, small bowel, gall‐bladder, and colonic physiology. It has been used to facilitate completion of colonoscopy and endoscopic retrograde cholangiopancreatography. Placebo controlled studies support its use in irritable bowel syndrome, functional dyspepsia, childhood functional abdominal pain, and post‐operative nausea. Few adverse effects have been reported in peppermint oil trials. Conclusion: Peppermint oil is a natural product which affects physiology throughout the gastrointestinal tract, has been used successfully for several clinical disorders, and appears to have a good safety profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple randomized controlled trials have demonstrated the efficacy of peppermint oil in alleviating IBS symptoms, suggesting its use as a promising treatment option for this condition [69].”
From Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies (2025) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Effects of menthol on circular smooth muscle of human colon: Analysis of the mechanism of action
Amato, A., Liotta, R., & Mulè, F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.018 · Cited by 98
Research works printed but not linked: 93
- 10.3109/19390211.2010.486702 · DOI
- 10.1136/bmjopen-2015-008375 · DOI
- 10.1016/j.phymed.2004.10.007 · DOI
- Vassallo S, 2001, Clinical Toxicology, 343
- 10.1111/j.1365-2125.1984.tb02519.x · DOI
- 10.1016/0378-5173(87)90060-3 · DOI
- 10.1053/cp.1999.v66.100455001 · DOI
- 10.1038/clpt.2011.110 · DOI
- 10.5650/jos.60.127 · DOI
- 10.2165/00003088-199937060-00004 · DOI · Paper page
- Yamaguchi T, 1994, Metabolic fate of [3H]‐l‐menthol in the rat, Drug Metab Dispos, 22, 616, 10.1016/S0090-9556(25)07522-1 · DOI
- 10.1111/j.1365-2036.1988.tb00677.x · DOI · Paper page
- 10.1016/0016-5085(91)90459-X · DOI
- 10.1159/000445549 · DOI · Paper page
- 10.1016/S0378-8741(97)00137-2 · DOI
- 10.3402/ljm.v7i0.16205 · DOI
- 10.1080/00365520500206442 · DOI
- 10.1523/JNEUROSCI.2221-07.2007 · DOI · Paper page
- 10.1074/jbc.M605213200 · DOI · Paper page
- 10.1016/j.pain.2013.06.043 · DOI · Paper page
- 10.1016/j.pain.2011.01.027 · DOI
- 10.1016/j.phytochem.2013.08.005 · DOI · Paper page
- 10.1111/j.1399-302X.1994.tb00059.x · DOI
- Imai H, 2001, Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria, Microbios, 106, 31
- Pattnaik S, 1996, Antibacterial and antifungal activity of ten essential oils in vitro, Microbios, 86, 237
- Pattnaik S, 1995, Effect of essential oils on the viability and morphology of Escherichia coli (SP‐11), Microbios, 84, 195
- 10.1186/1472-6882-13-338 · DOI
- 10.3389/fmicb.2015.00420 · DOI · Paper page
- 10.1016/j.fm.2015.08.006 · DOI
- 10.3389/fphar.2016.00170 · DOI
- 10.1016/j.ejphar.2017.03.003 · DOI · Paper page
- Juergens UR, 1998, The anti‐inflammatory activity of L‐menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases, Eur J Med Res, 3, 539
- 10.1016/j.molimm.2004.04.013 · DOI
- 10.1073/pnas.1217431110 · DOI
- 10.1080/00207450601042094 · DOI
- 10.1093/chemse/26.3.239 · DOI
- 10.1046/j.1440-1819.2000.00727.x · DOI
- 10.1016/j.pbb.2008.07.017 · DOI
- 10.1254/jphs.91.125 · DOI
- 10.1248/bpb.b13-00832 · DOI
- 10.1016/S0016-5085(69)80061-2 · DOI
- 10.1111/j.1440-1746.2006.04131.x · DOI
- 10.1097/00004836-200107000-00007 · DOI
- 10.1111/j.1443-1661.2011.01163.x · DOI
- 10.1007/s10620-012-2194-4 · DOI
- 10.1067/mge.2003.156 · DOI · Paper page
- 10.1002/(SICI)1099-1573(200002)14:1<20::AID-PTR542>3.0.CO;2-Z · DOI
- 10.1111/nmo.12102 · DOI
- 10.1002/ptr.1089 · DOI
- Dalvi SS, 1991, Effect of peppermint oil on gastric emptying in man: a preliminary study using a radiolabelled solid test meal, Indian J Physiol Pharmacol, 35, 212
- 10.1046/j.1365-2036.2003.01421.x · DOI
- 10.1111/j.1440-1746.2006.04307.x · DOI
- 10.1016/j.farma.2011.08.003 · DOI
- Wildgrube HJ, 1988, Untersuchungen zur Wirksamkeit von Pfefferminzöl auf Beschwerdebild und funktionelle Parameter bei Patienten mit Reizdarm‐Syndrom (Studie), Naturheilpraxis, 41, 591
- 10.1016/S0009-9260(02)00532-9 · DOI
- 10.1259/0007-1285-68-812-841 · DOI
- Duthie HL, 1981, The effect of peppermint oil on colonic motility in man, Br J Surg, 68, 820
- TaylorBA.Ultrasound used to measure the response of colonic motility to essential oils. Proceedings of the International Symposium on Gastrointestinal Motility. 1983:441‐8. · DOI
- 10.1067/mge.2000.108477 · DOI
- 10.1016/S0140-6736(82)90191-X · DOI
- Shavakhi A, 2012, Premedication with peppermint oil capsules in colonoscopy: a double blind placebo‐controlled randomized trial study, Acta Gastroenterol Belg, 75, 349
- 10.1055/s-0034-1365035 · DOI
- 10.1016/S0140-6736(88)90024-4 · DOI
- Nash P, 1986, Peppermint oil does not relieve the pain of irritable bowel syndrome, Br J Clin Pract, 40, 292, 10.1111/j.1742-1241.1986.tb07981.x · DOI
- Huertas‐Ceballos A, 2008, Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood, Cochrane Database Syst Rev, CD003017
- 10.1111/j.1572-0241.1998.00343.x · DOI · Paper page
- 10.1136/bmj.a2313 · DOI · Paper page
- 10.1097/MCG.0b013e3182a88357 · DOI
- 10.1067/mpd.2001.109606 · DOI · Paper page
- 10.5812/ircmj.17(4)2015.23844 · DOI
- Madisch A, 1999, Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference‐controlled double‐blind equivalence study, Arzneimittelforschung, 49, 925
- 10.1159/000076546 · DOI
- 10.1046/j.1365-2036.2000.00873.x · DOI
- 10.1111/nmo.13132 · DOI
- 10.1213/ANE.0b013e31824a0b1c · DOI
- 10.1177/0898010111423419 · DOI
- 10.1016/j.jopan.2013.09.008 · DOI
- Nair B, 2001, Final report on the safety assessment of Mentha Piperita (Peppermint) Oil, Mentha Piperita (Peppermint) Leaf Extract, Mentha Piperita (Peppermint) Leaf, and Mentha Piperita (Peppermint) Leaf Water, Int J Toxicol, 20, 61
- 10.1016/S0378-4274(98)00029-0 · DOI
- National Toxicology Program, 2011, Toxicology and carcinogenesis studies of pulegone (CAS No. 89‐82‐7) in F344/N rats and B6C3F1 mice (gavage studies), Natl Toxicol Program Tech Rep Ser, 1
- 10.4103/0019-5049.104585 · DOI
- 10.1073/pnas.0712314105 · DOI
- 10.1007/s00535-007-2067-3 · DOI
- Taylor BA, 1983, Gastrointestinal Motility Proceedings of the 9th International Symposium on Gastrointestinal Motility held in Aix‐en‐Provence, France, September 12–16, 1983, 441
- 10.1016/S0140-6736(88)90024-4 · DOI
- 10.1136/bmj.2.6194.835 · DOI
- Dew MJ, 1984, Peppermint oil for the irritable bowel syndrome: a multicentre trial, Br J Clin Pract, 38, 394, 10.1111/j.1742-1241.1984.tb07744.x · DOI
- 10.1007/BF02936952 · DOI · Paper page
- Capanni M, 2005, Efficacy of peppermint oil in the treatment of irritable bowel syndrome: a randomized, controlled trial, Gazz Med Ital, 164, 119
- 10.1016/j.dld.2007.02.006 · DOI · Paper page
- 10.1007/s10620-009-0854-9 · DOI · Paper page
- Alam MS, 2013, Efficacy of Peppermint oil in diarrhea predominant IBS ‐ a double blind randomized placebo ‐ controlled study, Mymensingh Med J, 22, 27
- 10.1007/s10620-015-3858-7 · DOI
Cited by
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893
Weerts, Z. Z. R. M., Masclee, A. A. M., Witteman, B. J. M., Clemens, C. H. M., Winkens, B., Brouwers, J. R. B. J., Frijlink, H. W., Muris, J. W. M., De Wit, N. J., Essers, B. A. B., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.026 · Cited by 137
Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome
Saito, Y. A., Almazar, A. E., Tilkes, K. E., Choung, R. S., Van Norstrand, M. D., Schleck, C. D., Zinsmeister, A. R., & Talley, N. J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15077 · Cited by 79
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies
Abalo, R., Gallego-Barceló, P., & Gabbia, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199345 · Cited by 5
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1
Metadata
- Authors
- Chumpitazi, B. P., Kearns, G. L., & Shulman, R. J.
- Affiliations
- Department of Pediatrics Baylor College of Medicine Houston TX USA
- Arkansas Children's Research Institute Little Rock AR USA
- ORCID
- Chumpitazi, B. P.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2018-01-26
- Volume
- 47
- Issue
- 6
- Pages
- 738-752
- ISSN
- 0269-2813
- 1365-2036
- Cited by
- 171
- References
- 2
- Language
- en
- Licence
- Funders
- National Institutes of Health (R01 NR013497, R21 AT009101, K23 DK101688, P30 DK56338)
- U.S. Department of Agriculture (6250‐51000‐043)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. https://app.cochat.ai/papers/10.1111/apt.14519
- The paper
- Chumpitazi, B. P., Kearns, G. L., & Shulman, R. J. (2018). Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.14519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.